Olgun, . Et Al. 2025. Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes. JOURNAL OF CLINICAL MEDICINE , vol.14, no.934 , 1-17.

Olgun, ., Arayıcı, M. E., Kızmazoğlu, D., & Çeçen, R. E., (2025). Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes. JOURNAL OF CLINICAL MEDICINE , vol.14, no.934, 1-17.

Olgun, Et Al. "Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes," JOURNAL OF CLINICAL MEDICINE , vol.14, no.934, 1-17, 2025

Olgun, Nur Et Al. "Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes." JOURNAL OF CLINICAL MEDICINE , vol.14, no.934, pp.1-17, 2025

Olgun, . Et Al. (2025) . "Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes." JOURNAL OF CLINICAL MEDICINE , vol.14, no.934, pp.1-17.

@article{article, author={ Nur Olgun Et Al. }, title={Assessment of Chemo-Immunotherapy Regimens in Patients with Refractory or Relapsed Neuroblastoma: A Systematic Review with Meta-Analysis of Critical Oncological Outcomes}, journal={JOURNAL OF CLINICAL MEDICINE}, year=2025, pages={1-17} }